Results 151 to 160 of about 16,179 (202)
Some of the next articles are maybe not open access.
Progressive supranuclear palsy
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 2021Progressive supranuclear palsy (PSP) is a heterogeneous progressive neurodegenerative disease characterized by onset after 50 years old, Parkinson's syndrome, early development of postural instability, absence or transient reaction to levodopa drugs, neuropsychological disorders, dysphagia and dysarthria and eye movement disorders.
N V, Fedorova +3 more
openaire +2 more sources
Progressive supranuclear palsy
Neurology, 1982To the Editor.— I appreciated the letter to the editor "Progressive Supranuclear Palsy Despite Normal Eye Movements" by Dr Nuwer (Archives1981;38:784). In the case reported by Dr Nuwer, the diagnosis was supported by electronystagmography, which showed typical changes, and pneumoencephalography, which demonstrated pontine and midbrain atrophy ...
G W, Hynd, F J, Pirozzolo, G J, Maletta
+7 more sources
PROGRESSIVE SUPRANUCLEAR PALSY
Age and Ageing, 1977In the past four years, four patients with progressive supranuclear palsy have presented to the Department of Geriatric Medicine, Oxford, under the care of one of us (RAG). They were all females whose symptoms began in the sixth or seventh decade. They died from three to six years after the onset of symptoms. All had neuropathological studies which are
J A, Dalziel, R A, Griffiths
openaire +2 more sources
Progressive supranuclear palsy
Parkinsonism & Related Disorders, 2012Progressive supranuclear palsy (PSP) is a neurodegenerative tauopathy which can manifest clinically in a variety of syndromes. In this review, the classic and most common variant syndrome -PSP-Richardson's syndrome (PSP-RS) -is the focus, with the core clinical features, varying cognitive/motor/neuropsychiatric/sleep manifestations, neuropsychological ...
Loretta, Mazorra, Mary P, Cadogan
openaire +4 more sources
Progressive Supranuclear Palsy
Science of Aging Knowledge Environment, 2004In this case study, we describe the symptoms, neurological examination, clinical course, and neuropathology of a patient with progressive supranuclear palsy (PSP). PSP is a relatively uncommon neurodegenerative disorder with many features similar to those of Parkinson's disease .
Michael, Pourfar, Jean-Paul, Vonsattel
openaire +2 more sources
Progressive supranuclear palsy
2007![Graphic][1] A typical PSP patient. Note the marked reduction in facial expression and frontalis overactivity. Progressive supranuclear palsy (PSP) is a neurodegenerative disease, classified pathologically as a tauopathy, which all neurologists encounter from time to time.
Burn D, Lees A
openaire +3 more sources
Progressive supranuclear palsy
Nursing Standard, 2013Progressive supranuclear palsy (PSP), or Steele-Richardson-Olszewski syndrome, is a rare, progressive neurodegenerative condition with cognitive and motor involvement. Diagnosis can be challenging as some people do not display the classic symptoms of the condition and there are no specific investigations to confirm diagnosis.
openaire +2 more sources
Hypertension and progressive supranuclear palsy
Parkinsonism & Related Disorders, 2019The epidemiologic evidence of whether hypertension is associated with Progressive Supranuclear Palsy (PSP) is inconsistent. The ENGENE-PSP case-control study determined various PSP risk factors including whether hypertension preceded PSP onset.Incident PSP cases per NINDS-PSP criteria and age-, sex-, race- matched controls were recruited from similar ...
Soniya V. Rabadia +11 more
openaire +2 more sources
Progressive Supranuclear Palsy
The Neurologist, 2008Progressive supranuclear palsy (PSP) is the second most common cause of parkinsonism after Parkinson's disease (PD). The classic syndrome of PSP is widely recognized by neurologists as a combination of down gaze palsy with progressive rigidity and imbalance leading to falls.
Michael, Lubarsky, Jorge L, Juncos
openaire +2 more sources